While heart disease is often thought of as mainly being influenced by lifestyle factors, genetics can play a greater role in some people.
Transcatheter aortic valve replacement (also known as TAVR or TAVI) is a minimally invasive procedure used by physicians at the Massachusetts General Hospital Corrigan Minhean Heart Center to treat patients with aortic valve stenosis.
Patients who have severe aortic stenosis (a narrowing of the valve that restricts blood flow) and are considered high risk or non-operable for open-heart surgery may be candidates for the transcatheter aortic valve replacement (also known as TAVR or TAVI) procedure.
About The Procedure
During this procedure, physicians use minimally invasive techniques to implant a new heart valve without open-heart surgery. Physicians use a transfemoral (from the leg), transaxillary (from the shoulder), or transapical (through the chest) approach, by inserting a transcatheter heart valve that is mounted and crimped onto a balloon delivery catheter. It is then threaded through the patient’s circulatory system and directly into the heart’s pumping chamber.
Upon reaching the site of the patient’s diseased heart valve, the balloon expands, and the transcatheter heart valve is deployed across the patient’s diseased valve. This procedure is performed on a beating heart, meaning that there is no need for a cardiopulmonary bypass and its associated risks.
Transcatheter aortic valve replacement has been proven to have superior safety and efficacy and is currently approved by the US Food and Drug Administration for patients with aortic valve stenosis that are at high or extreme risk for open-heart surgery. Healthier patients may have an opportunity to receive transcatheter aortic valve replacement through one of our ongoing clinical studies.
Ongoing Clinical Trials
- The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves
- Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Our multidisciplinary care team includes cardiac surgeons, interventional cardiologists, noninvasive cardiologists, cardiac anesthesiologists, cardiac imaging specialists, nurse practitioners, registered nurses and technicians with robust experience in the evaluation and treatment of patients with valvular heart disease. Patients referred to us undergo a thorough evaluation in order to determine the treatment option that would be best for the patient. Specifically, all patients being considered for TAVR will receive:
- Cardiac catheterization
- Transthoracic echocardiogram
- Cardiac computed tomography scan (CAT scan)
- Pulmonary function testing
- Carotid artery ultrasound
- Mar | 26 | 2021
Malissa Wood, MD, cardióloga de Mass General, afirma que el entorno, incluyendo los amigos, la familia y el lugar de trabajo, puede influir en su salud del corazón.
- Press Release
- Mar | 26 | 2021
A new study uncovers potential mechanisms that may contribute to “broken heart syndrome,” or Takotsubo syndrome (TTS), a temporary heart condition that is brought on by stressful situations and emotions.
- Feb | 18 | 2021
Christopher Learn, MD, of the Corrigan Minehan Heart Center and Department of Medicine, reviews the opportunities and challenges of adolescents and young adults transitioning to adult care providers.
- Feb | 5 | 2021
Michael Honigberg, MD, reviews the epidemiology of heart disease in women, differences in heart disease between women and men, unique sex-specific risk factors for heart disease in women and special considerations for promoting female heart health.
- Press Release
- Feb | 4 | 2021
Fine particulate air pollution stimulates production of inflammatory cells, leading to inflammation of the arteries.